Experts explain why daydreaming could actually be key to a productive day
What our brains really need is some much-needed time off from concentrating. By not consciously focusing on anything and allowing the mind to drift, this can reduce stress and improve cognitive sharpness.
This can often be easier said than done. But attention restoration theory (Art) can help you learn to give your brain space to drift. While this might sound like a fancy name for doing nothing, the theory is supported by neuroscience.
Attention restoration theory was first put forward by psychologists Rachel and Stephen Kaplan in 1989. They theorised that spending time in nature can help restore focus and attention.
They proposed there are two distinct types of attention: directed attention and undirected attention. Directed attention refers to deliberate concentration – such as studying, navigating through a busy place or posting on social media. Basically, it's any activity where our brain's attention is being directed at a specific task.
Undirected attention is when we're not consciously trying to focus on anything – instead allowing things to gently capture our attention without trying. Think listening to chirping birds or watching leaves gently rustling in the breeze. In these instances, your attention naturally drifts without having to force your focus.
Without time for undirected attention, it's thought that we experience 'attentional fatigue'. This can make it increasingly difficult to focus and concentrate, while distractions become more likely to grab our attention.
In the past, we encountered many situations in our daily lives that we might classify as 'boring'. Moments such as waiting for the bus or standing in the supermarket queue. But these dull moments also gave our minds a chance to switch off.
Now, our smartphones give us the opportunity for constant entertainment. Being able to constantly expose ourselves to intense, gripping stimuli offers little mental space for our overworked brains to recover.
But attention restoration theory shows us how important it is to create space for moments that allow our brains to 'reset'.
Restoring attention
The origins of Kaplan and Kaplan's theory can actually be traced back to the 19th century. American psychologist William James was the first to formulate the concept of 'voluntary attention' – attention that requires effort. James' ideas were published against the backdrop of the broader cultural movement of Romanticism, which lauded nature.
Romantic ideas about the restorative power of nature have since been backed by research – with numerous studies showing links between time in nature and lower stress levels, better attention, improvements in mental health, mood and better cognitive function.
The restorative benefits of nature are backed by neuroscience, too. Neuroimaging has shown that activity in the amygdala – the part of the brain associated with stress and anxiety – was reduced when people were exposed to natural environments. But when exposed to urban environments, this activity was not reduced.
Numerous studies have also since backed up Kaplan and Kaplan's theory that time in nature can help to restore attention and wellbeing. One systematic review of 42 studies found an association with exposure to natural environments and improvements in several aspects of cognitive performance – including attention.
A randomised controlled trial using neuroimaging of the brain found signs of lower stress levels in adults who took a 40-minute walk in a natural environment, compared to participants who walked in an urban environment. The authors concluded that the nature walk facilitated attention restoration.
Research has even shown that as little as ten minutes of undirected attention can result in a measurable uptick in performance on cognitive tests, as well as a reduction in attentional fatigue. Even simply walking on a treadmill while looking at a nature scene can produce this cognitive effect.
Time in nature
There are many ways you can put attention restoration theory to the test on your own. First, find any kind of green space – whether that's your local park, a river you can sit beside or a forest trail you can hike along. Next, make sure you put your phone and any other distractions away.
Or, when you face boring moments during your day, instead of picking up your phone try seeing the pause as an opportunity to let your mind wander for a bit.
Each of us may find certain environments to be more naturally supportive in allowing us to switch off and disengage the mind. So, if while trying to put attention restoration theory into practice, you find your brain pulling you back to structured tasks (such as mentally planning your week), this may be sign you should go someplace where it's easier for your mind to wander.
Whether you're watching a ladybird crawl across your desk or visiting a vast expanse of nature, allow your attention to be undirected. It's not laziness, it's neurological maintenance.
Anna Kenyon is a Senior Lecturer in Population Health at the University of Lancashire.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
BRISBANE, Calif., August 06, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of Nathan Smith to the role of Chief Financial Officer. Nathan will lead key financial and accounting initiatives that are a part of the Company's long-term strategic growth plan. Nathan brings more than 14 years of experience in the molecular diagnostics industry, including senior finance leadership roles at Myriad Genetics and recent CFO positions at Blackrock Neurotech and WIN Brands. "Nathan's deep financial expertise in molecular diagnostics is a great fit for CareDx," said John Hanna, CEO of CareDx. "His track record of operational excellence and experience in supporting diagnostics companies to scale efficiently will be invaluable as we enter our next phase." In conjunction with this appointment, the Company also announced that Abhishek Jain will be retiring from his role as Chief Financial Officer. Abhishek will continue to support CareDx in a consulting capacity to ensure a seamless transition. "On behalf of the Board and the entire CareDx team, I want to express my sincere gratitude to Abhishek for his outstanding leadership as CFO," said John Hanna. "Abhishek's disciplined financial management, stewardship through our CEO transition, and dedication to strengthening our finance function have positioned CareDx for continued success. We wish him all the best." About CareDx CareDx, Inc., headquartered in Brisbane, California, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, visit Forward Looking Statements This press release includes forward-looking statements related to CareDx, Inc. These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including general economic and market factors and other risks discussed in CareDx's filings with the SEC, including, but not limited to, the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by CareDx with the SEC on February 28, 2025, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed by CareDx with the SEC on April 30, 2025, and other reports that CareDx has filed with the SEC. Any of these may cause CareDx's actual results, performance, or achievements to differ materially and adversely from those anticipated or implied by CareDx's forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise. View source version on Contacts CareDx Media Contacts Natasha Moshirian Wagnernwagner@ Investor RelationsCaroline Cornerinvestor@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15 minutes ago
- Yahoo
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.


CBS News
17 minutes ago
- CBS News
Baltimore organizations try to keep the momentum going with overdose prevention
Some Baltimore organizations are working around the clock to combat drug abuse while trying to prevent residents from overdosing. The Pride Center of Maryland's Harm Reduction Team was in action on Wednesday in the city's Old Gaucher neighborhood, handing out resources, including Narcan. Those getting this help say this work is sorely needed, adding it's a life-or-death situation. Every day, members of the Pride Center of Maryland's Harm Reduction Team are outside the nonprofit's resource center on Maryland Avenue. They're sitting at tables, which are filled with food, hygiene products, clothes -- as well as Narcan, fentanyl strips, and other health resources. It's free for anyone who walks by. Jerome Scott, the Pride Center's program manager of wellness, said the purpose is about visibility and to let people know they are here to help. "[Let people know] we see you, we care, and we have things for you," Scott said. "We just like to let our faces be known." But, they aren't just stationary. Scott packed a few drawstring bags with what was on the tables and walked several blocks around the neighborhood, handing them out to anyone he saw. A volunteer also handed out lunches alongside him. Scott said there are times he would leave Narcan and other resources in certain locations, even if no one is there, so it can be readily accessible if someone were to use it nearby. Scott stressed that it's important this work doesn't lose momentum. "These are our brothers, these are our sisters, our aunts, our uncles out here. So, we wanna be there for them," Scott said. Scott said the mass overdoses in the Penn North neighborhood in July show why this work can't slow down. Penn North is another neighborhood where Scott does outreach and brings resources to. Jessica Collins, who received some of the Pride Center's free resources, said she's also been in an addiction treatment center since May. She said these resources need to be more accessible to encourage addicts to get help. "It's just each individual taking that step to go forward to wanting that that person making that decision to want to get help," Collins said. When asked how much Narcan his team has on hand, Scott said they try to have at least 500. However, the team goes through its inventory often, especially in the summer months.